Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GetMyDNA was a U.S. healthcare testing company and consumer brand launched by Gravity Diagnostics in 2018 to offer at-home diagnostic testing. Its main offerings included an FDA-authorized COVID-19 home collection kit and a consumer-initiated pharmacogenetics test kit designed to help guide medication selection and dosing. The company positioned itself as a direct-to-consumer home-testing business backed by telemedicine and processed samples through Gravity Diagnostics' CLIA-certified, CAP-accredited laboratory infrastructure. Available evidence indicates GetMyDNA functioned primarily as a brand/subsidiary of Gravity Diagnostics rather than an independent therapeutics developer. The brand appears to be inactive as a standalone operating company, with COVID-19 authorization and related activities later updated under Gravity Diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GetMyDNA.